Prestige Consumer Healthcare Inc. - Common Stock SH (PBH)

Historical Holders from Q1 2014 to Q3 2025

Symbol
PBH on NYSE
Type / Class
Equity / Common Stock SH
Shares outstanding
49.2M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
51M
Holdings value
$3.18B
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
348
Number of buys
163
Number of sells
-191
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Prestige Consumer Healthcare Inc. - Common Stock SH (PBH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 15.2% $636M 7.52M BlackRock, Inc. 31 Mar 2025
ARIEL INVESTMENTS, LLC 7.3% +56% $224M $86.9M 3.59M +63.2% Ariel Investments, LLC 30 Sep 2025
DIMENSIONAL FUND ADVISORS LP 5.9% $246M 2.91M Dimensional Fund Advisors LP 31 Dec 2024
MACQUARIE GROUP LTD 4.67% $195M 2.31M Macquarie Group Limited 31 Dec 2024

Institutional Holders of Prestige Consumer Healthcare Inc. - Common Stock SH (PBH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 51M $3.18B -$64.8M $62.40 348
2025 Q2 52M $4.15B +$68.7M $79.85 373
2025 Q1 51.2M $4.4B -$95.1M $85.97 353
2024 Q4 52.5M $4.1B +$128M $78.09 334
2024 Q3 50.5M $3.65B -$31.9M $72.10 320
2024 Q2 51M $3.51B +$28.2M $68.85 303
2024 Q1 50.8M $3.69B -$35M $72.56 309
2023 Q4 129K $7.92M +$1.2M $61.22 2
2023 Q3 50M $2.86B +$57.4M $57.19 274
2023 Q2 48.9M $2.91B -$76.1M $59.43 269
2023 Q1 49.8M $3.12B +$46.9M $62.63 277
2022 Q4 49.4M $3.09B +$2.9M $62.60 282
2022 Q3 48.1M $2.4B -$25.2M $49.83 262
2022 Q2 50.6M $2.96B +$34.9M $58.80 271
2022 Q1 50.4M $2.67B -$38.1M $52.94 267
2021 Q4 50.5M $3.06B -$86.7M $60.65 259
2021 Q3 50.7M $2.85B -$66.7M $56.11 240
2021 Q2 51.9M $2.71B -$31M $52.10 220
2021 Q1 52.4M $2.31B +$9.58M $44.08 234
2020 Q4 52.1M $1.82B -$31.9M $34.87 223
2020 Q3 51.8M $1.88B -$68.9M $36.42 229
2020 Q2 55M $2.06B +$16.3M $37.56 245
2020 Q1 54.4M $2B -$230M $36.68 239
2019 Q4 60.1M $2.43B +$63.5M $40.50 221
2019 Q3 60M $2.08B -$40.7M $34.69 220
2019 Q2 61.7M $1.95B -$60.1M $31.68 200
2019 Q1 64.5M $1.93B +$1.58M $29.91 210
2018 Q4 62M $1.91B -$18M $30.88 222
2018 Q3 64.6M $2.45B +$43.8M $37.89 223
2018 Q2 63.5M $2.44B -$4.67M $38.38 223
2018 Q1 64.4M $2.17B +$69.1M $33.72 227
2017 Q4 60.5M $2.69B +$135M $44.41 241
2017 Q3 57.6M $2.88B +$207M $50.09 234
2017 Q2 53.3M $2.82B +$89.6M $52.81 225
2017 Q1 52.7M $2.93B +$404M $55.56 233
2016 Q4 51.5M $2.68B -$37.6M $52.10 229
2016 Q3 52.2M $2.51B -$16.4M $48.27 236
2016 Q2 52.4M $2.91B -$24.5M $55.40 261
2016 Q1 53.5M $2.86B +$45.7M $53.39 252
2015 Q4 53.1M $2.73B +$4.4M $51.48 231
2015 Q3 53M $2.39B -$9.22M $45.16 204
2015 Q2 52.7M $2.44B -$22M $46.24 203
2015 Q1 53.8M $2.31B -$37.5M $42.89 193
2014 Q4 55.2M $1.92B +$23.9M $34.72 175
2014 Q3 54.5M $1.76B +$44.8M $32.37 173
2014 Q2 52.5M $1.78B +$51.5M $33.89 181
2014 Q1 52.2M $1.42B +$11.8M $27.25 167